The Neuropsychopharmacology of Phencyclidine: From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia

[1]  A. Carlsson,et al.  EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. , 2009, Acta pharmacologica et toxicologica.

[2]  R. Roth,et al.  Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits , 1999, Neuroscience.

[3]  Hank P Jedema,et al.  Clozapine Preferentially Increases Dopamine Release in the Rhesus Monkey Prefrontal Cortex Compared with the Caudate Nucleus , 1999, Neuropsychopharmacology.

[4]  R. Y. Wang,et al.  Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine. , 1999, The Journal of pharmacology and experimental therapeutics.

[5]  H. Moore,et al.  Role of accumbens and cortical dopamine receptors in the regulation of cortical acetylcholine release , 1999, Neuroscience.

[6]  K. Davis,et al.  AMPA Receptor Binding and Subunit mRNA Expression in Prefrontal Cortex and Striatum of Elderly Schizophrenics , 1998, Neuropsychopharmacology.

[7]  S. Hjorth,et al.  Systemic PCP treatment elevates brain extracellular 5‐HT: a microdialysis study in awake rats , 1998, Neuroreport.

[8]  B. Moghaddam,et al.  Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. , 1998, Science.

[9]  R. Roth,et al.  Subchronic Phencyclidine Administration Increases Mesolimbic Dopaminergic System Responsivity and Augments Stress- and Psychostimulant-Induced Hyperlocomotion , 1998, Neuropsychopharmacology.

[10]  B. Moghaddam,et al.  Corticolimbic Dopamine Neurotransmission Is Temporally Dissociated from the Cognitive and Locomotor Effects of Phencyclidine , 1998, The Journal of Neuroscience.

[11]  R. Roth,et al.  Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence , 1998, Psychopharmacology.

[12]  Rex Y. Wang,et al.  M100907 and Clozapine, but not Haloperidol or Raclopride, Prevent Phencyclidine-Induced Blockade of NMDA Responses in Pyramidal Neurons of the Rat Medial Prefrontal Cortical Slice , 1998, Neuropsychopharmacology.

[13]  T. Woo,et al.  A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Svensson,et al.  Non‐NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK‐801) induced hyperlocomotion and dopamine release in the nucleus accumbens , 1998, Journal of neuroscience research.

[15]  R. Freedman,et al.  Improvement in Smooth Pursuit Eye Movements after Cigarette Smoking in Schizophrenic Patients , 1998, Neuropsychopharmacology.

[16]  Leslie G. Ungerleider,et al.  An area specialized for spatial working memory in human frontal cortex. , 1998, Science.

[17]  J. Arnt,et al.  Do Novel Antipsychotics Have Similar Pharmacological Characteristics? A Review of the Evidence , 1998, Neuropsychopharmacology.

[18]  Takeshi Kawahara,et al.  Involvement of γ-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex , 1998 .

[19]  R. Roth,et al.  α‐noradrenergic receptor modulation of the phencyclidine‐ and Δ9‐tetrahydrocannabinol‐induced increases in dopamine utilization in rat prefrontal cortex , 1998 .

[20]  C. Tamminga,et al.  Antipsychotic Properties of the Partial Dopamine Agonist (−)-3-(3-Hydroxyphenyl)-N-n-Propylpiperidine (Preclamol) in Schizophrenia , 1998, Biological Psychiatry.

[21]  T. Braver,et al.  596 CNS catecholamines and cognitive dysfunction in schizophrenia , 1997, Schizophrenia Research.

[22]  T. Robbins,et al.  Dissociable Forms of Inhibitory Control within Prefrontal Cortex with an Analog of the Wisconsin Card Sort Test: Restriction to Novel Situations and Independence from “On-Line” Processing , 1997, The Journal of Neuroscience.

[23]  J A Frank,et al.  Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: a proton magnetic resonance spectroscopic imaging study. , 1997, Cerebral cortex.

[24]  K. Hikosaka,et al.  Increase of extracellular dopamine in primate prefrontal cortex during a working memory task. , 1997, Journal of neurophysiology.

[25]  A. Malhotra,et al.  Clozapine Blunts N-Methyl-d-Aspartate Antagonist-Induced Psychosis: A Study with Ketamine , 1997, Biological Psychiatry.

[26]  R W Neufeld,et al.  Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. , 1997, Archives of general psychiatry.

[27]  R. Ridley,et al.  The effect of dizocilpine (MK‐801) on conditional discrimination learning in the rat , 1997, Behavioural pharmacology.

[28]  Jeffrey A Lieberman,et al.  Neurochemical Sensitization in the Pathophysiology of Schizophrenia: Deficits and Dysfunction in Neuronal Regulation and Plasticity , 1997, Neuropsychopharmacology.

[29]  J. Jentsch,et al.  The Alpha-1 Adrenergic Agonist, Cirazoline, Impairs Spatial Working Memory Performance in Aged Monkeys , 1997, Pharmacology Biochemistry and Behavior.

[30]  K. Chergui,et al.  Chronic Nicotine Enhances Basal and Nicotine-Induced Fos Immunoreactivity Preferentially in the Medial Prefrontal Cortex of the Rat , 1997, Neuropsychopharmacology.

[31]  Anil K Malhotra,et al.  Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics , 1997, Neuropsychopharmacology.

[32]  R. Roth,et al.  Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. , 1997, Science.

[33]  R. Roth,et al.  Subchronic Phencyclidine Administration Reduces Mesoprefrontal Dopamine Utilization and Impairs Prefrontal Cortical-Dependent Cognition in the Rat , 1997, Neuropsychopharmacology.

[34]  T. Svensson,et al.  Risperidone Dose-Dependently Increases Extracellular Concentrations of Serotonin in the Rat Frontal Cortex: Role of α2 –Adrenoceptor Antagonism , 1997, Neuropsychopharmacology.

[35]  N. Lindefors,et al.  Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex , 1997, Brain Research.

[36]  R. Roth,et al.  Δ9-Tetrahydrocannabinol Increases Prefrontal Cortical Catecholaminergic Utilization and Impairs Spatial Working Memory in the Rat: Blockade of Dopaminergic Effects with HA966 , 1997, Neuropsychopharmacology.

[37]  M. Shapiro,et al.  Effects of NMDA receptor blockade on behaviors differentially affected by fimbria/fornix and amygdala lesions , 1997, Psychobiology.

[38]  J. Fuster.  The Prefrontal Cortex , 1997 .

[39]  B. El-Khodor,et al.  Long-Term Reciprocal Changes in Dopamine Levels in Prefrontal Cortex versus Nucleus Accumbens in Rats Born by Caesarean Section Compared to Vaginal Birth , 1997, Experimental Neurology.

[40]  T. Robbins,et al.  Altered decision-making following frontal lesions: a comparison with amphetamine and opiate addicts , 1997 .

[41]  Bita Moghaddam,et al.  Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex , 1997, The Journal of Neuroscience.

[42]  T. Stone,et al.  Purine modulation of dizocilpine effects on spontaneous alternation , 1997, Psychopharmacology.

[43]  J. Olney,et al.  Multifocal brain damage induced by phencyclidine is augmented by pilocarpine , 1997, Brain Research.

[44]  A. Malhotra,et al.  Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[45]  R. Roth,et al.  Phencyclidine Increases Forebrain Monoamine Metabolism in Rats and Monkeys: Modulation by the Isomers of HA966 , 1997, The Journal of Neuroscience.

[46]  D. Weinberger,et al.  Dopamine, the prefrontal cortex and schizophrenia , 1997, Journal of psychopharmacology.

[47]  M. Iyo,et al.  Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET , 1997, Nature.

[48]  F. Vollenweider,et al.  Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG) , 1997, European Neuropsychopharmacology.

[49]  C R Ashby,et al.  Pharmacological actions of the atypical antipsychotic drug clozapine: A review , 1996, Synapse.

[50]  R. Roth,et al.  Dopamine and Spatial Working Memory in Rats and Monkeys: Pharmacological Reversal of Stress-Induced Impairment , 1996, The Journal of Neuroscience.

[51]  N. Swerdlow,et al.  Seroquel restores sensorimotor gating in phencyclidine-treated rats. , 1996, The Journal of pharmacology and experimental therapeutics.

[52]  E. Levin,et al.  Nicotine–Haloperidol Interactions and Cognitive Performance in Schizophrenics , 1996, Neuropsychopharmacology.

[53]  D. Weinberger,et al.  Prefrontal function in schizophrenia: confounds and controversies. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[54]  T. Robbins.  Dissociating executive functions of the prefrontal cortex. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[55]  A. Diamond,et al.  Evidence for the importance of dopamine for prefrontal cortex functions early in life. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[56]  M. Petrides,et al.  Specialized systems for the processing of mnemonic information within the primate frontal cortex. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[57]  A C Roberts,et al.  Primate analogue of the Wisconsin Card Sorting Test: effects of excitotoxic lesions of the prefrontal cortex in the marmoset. , 1996, Behavioral neuroscience.

[58]  F. Dickerson,et al.  Neurocognitive deficits and social functioning in outpatients with schizophrenia , 1996, Schizophrenia Research.

[59]  J. Krystal,et al.  Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[60]  T. Svensson,et al.  Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens. , 1996, European journal of pharmacology.

[61]  C. Tamminga,et al.  Phencyclidine produces changes in NMDA and kainate receptor binding in rat hippocampus over a 48‐hour time course , 1996, Synapse.

[62]  J. Olney,et al.  Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity , 1996, Schizophrenia Research.

[63]  P. Salmi,et al.  Further evidence for clozapine as a dopamine D1 receptor agonist. , 1996, European journal of pharmacology.

[64]  J. Meador-Woodruff,et al.  Dopamine receptor gene expression in hippocampus is differentially regulated by the NMDA receptor antagonist MK-801. , 1996, European journal of pharmacology.

[65]  P. Goldman-Rakic,et al.  Localization of dopamine D4 receptors in GABAergic neurons of the primate brain , 1996, Nature.

[66]  Herbert Weingartner,et al.  NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers , 1996, Neuropsychopharmacology.

[67]  T. Svensson,et al.  Condition‐independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat , 1996, Synapse.

[68]  A. Grace,et al.  454. Hippocampal gating of cortical throughput in the nucleus accumbens: Modulation by dopamine , 1996, Biological Psychiatry.

[69]  T. Nishikawa,et al.  Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis , 1996, Synapse.

[70]  M. Hasselmo,et al.  NMDA-dependent modulation of CA1 local circuit inhibition , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[71]  T. Robbins,et al.  Dissociation in prefrontal cortex of affective and attentional shifts , 1996, Nature.

[72]  P S Goldman-Rakic,et al.  Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[73]  J. Meador-Woodruff,et al.  Differential regulation, by MK-801, of dopamine receptor gene expression in rat nigrostriatal and mesocorticolimbic systems , 1996, Brain Research.

[74]  R. Steinpreis.  The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis , 1996, Behavioural Brain Research.

[75]  J. Olney,et al.  MK-801 neurotoxicity in male mice: histologic effects and chronic impairment in spatial learning , 1996, Brain Research.

[76]  P. Hutson,et al.  Effects of and interactions between antagonists for different sites on the NMDA receptor complex on hippocampal and striatal acetylcholine efflux in vivo. , 1996, European journal of pharmacology.

[77]  B. Moghaddam,et al.  NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[78]  F. Sams-Dodd.  Phencyclidine‐induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia , 1996, Behavioural pharmacology.

[79]  T. Svensson,et al.  Effects of d-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat , 1995, Behavioural Brain Research.

[80]  J. Olney,et al.  Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.

[81]  P. Goldman-Rakic,et al.  Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[82]  M. Paule,et al.  Acute behavioral effects of phencyclidine on rhesus monkey performance in an operant test battery , 1995, Pharmacology Biochemistry and Behavior.

[83]  Karl J. Friston,et al.  Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia , 1995, Nature.

[84]  P. Shepard,et al.  Effects of the enantiomers of (+/-)-HA-966 on dopamine neurons: an electrophysiological study of a chiral molecule. , 1995, European journal of pharmacology.

[85]  P. Goldman-Rakic,et al.  Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. , 1995, Archives of general psychiatry.

[86]  D. Lewis,et al.  The functional architecture of the prefrontal cortex and schizophrenia , 1995, Psychological Medicine.

[87]  Carol A. Tamminga,et al.  Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia , 1995, Neuropsychopharmacology.

[88]  M. Galloway,et al.  Dopamine D3-preferring ligands act at synthesis modulating autoreceptors. , 1995, The Journal of pharmacology and experimental therapeutics.

[89]  M. Millan,et al.  Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors. , 1995, European journal of pharmacology.

[90]  F. Sams-Dodd,et al.  Automation of the social interaction test by a video-tracking system: behavioural effects of repeated phencyclidine treatment , 1995, Journal of Neuroscience Methods.

[91]  A. Grace,et al.  Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[92]  D R Medoff,et al.  Ketamine activates psychosis and alters limbic blood flow in schizophrenia , 1995, Neuroreport.

[93]  H. Tomita,et al.  Changes in dopamine D2 and GluR-1 glutamate receptor mRNAs in the rat brain after treatment with phencyclidine. , 1995, Acta medica Okayama.

[94]  M. Martres,et al.  Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain , 1995, Neuroscience.

[95]  E. G. Jones,et al.  Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. , 1995, Archives of general psychiatry.

[96]  J. Grotta,et al.  Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial. , 1995, Stroke.

[97]  C. J. Schmidt,et al.  The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat. , 1995, European journal of pharmacology.

[98]  G. Ellison.  The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias , 1995, Brain Research Reviews.

[99]  R. Nadal,et al.  Effects Of ketamine, a noncompetitive NMDA antagonist, on the acquisition of the lever-press response in rats , 1995, Physiology & Behavior.

[100]  H. Meltzer.  The Role of Serotonin in Schizophrenia and the Place of Serotonin‐Dopamine Antagonist Antipsychotics , 1995, Journal of clinical psychopharmacology.

[101]  F. Bloom,et al.  Psychopharmacology: The Fourth Generation of Progress , 1995 .

[102]  G. Ellison,et al.  Competitive and non-competitive NMDA antagonists induce similar limbic degeneration. , 1994, Neuroreport.

[103]  N. Swerdlow,et al.  Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. , 1994, The Journal of pharmacology and experimental therapeutics.

[104]  E. French.  Phencyclidine and the midbrain dopamine system: electrophysiology and behavior. , 1994, Neurotoxicology and teratology.

[105]  P. Goldman-Rakic,et al.  A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[106]  A C Roberts,et al.  6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[107]  L. Aguado,et al.  Effects of the NMDA receptor antagonist ketamine on flavor memory: conditioned aversion, latent inhibition, and habituation of neophobia. , 1994, Behavioral and neural biology.

[108]  J. Salamone,et al.  The effects of haloperidol and clozapine on PCP- and amphetamine-induced suppression of social behavior in the rat , 1994, Pharmacology Biochemistry and Behavior.

[109]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[110]  L. Bianchi,et al.  NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus: a microdialysis study , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[111]  E. Domino,et al.  Phencyclidine-induced behavioral sensitization , 1994, Pharmacology Biochemistry and Behavior.

[112]  R. Buchanan,et al.  The Effect of Clozapine on Plasma Norepinephrine: Relationship to Clinical Efficacy , 1994, Neuropsychopharmacology.

[113]  B. Weiss,et al.  Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain. , 1994, Brain research. Molecular brain research.

[114]  N. Tashiro,et al.  Effect of phenycyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study , 1994, Brain Research.

[115]  R. Roth,et al.  Preferential activation of dopamine overflow in prefrontal cortex produced by chronic clozapine treatment , 1994, Neuroscience Letters.

[116]  Y. Agid,et al.  Delayed response tasks and prefrontal lesions in man—Evidence for self generated patterns of behaviour with poor environmental modulation , 1993, Neuropsychologia.

[117]  A. Wiser,et al.  Normalization of auditory physiology by cigarette smoking in schizophrenic patients. , 1993, The American journal of psychiatry.

[118]  R. Switzer,et al.  Dissimilar patterns of degeneration in brain following four different addictive stimulants , 1993, Neuroreport.

[119]  C. Tamminga,et al.  Delayed regional metabolic actions of phencyclidine. , 1993, European journal of pharmacology.

[120]  H. Meltzer,et al.  The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux. , 1993, European journal of pharmacology.

[121]  D. Weinberger,et al.  Postpubertal Emergence of Hyperresponsiveness to Stress and to Amphetamine after Neonatal Excitotoxic Hippocampal Damage: A Potential Animal Model of Schizophrenia , 1993, Neuropsychopharmacology.

[122]  J. Olney,et al.  Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity , 1993, Biological Psychiatry.

[123]  H. Ogura,et al.  MK-801 impairs recognition memory in rhesus monkeys: comparison with cholinergic drugs. , 1993, The Journal of pharmacology and experimental therapeutics.

[124]  H. Fibiger,et al.  Dopaminergic regulation of cortical acetylcholine release: Effects of dopamine receptor agonists , 1993, Neuroscience.

[125]  J. Salamone,et al.  The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study , 1993, Brain Research.

[126]  T J Hudzik,et al.  Effects of drugs of abuse and cholinergic agents on delayed matching-to-sample responding in the squirrel monkey. , 1993, The Journal of pharmacology and experimental therapeutics.

[127]  M. Akil,et al.  The catecholaminergic innervation of the human entorhinal cortex , 1993, Schizophrenia Research.

[128]  T. Svensson,et al.  Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. , 1993, European journal of pharmacology.

[129]  R. Kesner,et al.  Phencyclidine disrupts acquisition and retention performance within a spatial continuous recognition memory task , 1993, Pharmacology Biochemistry and Behavior.

[130]  H. Fibiger,et al.  Dopaminergic regulation of cortical acetylcholine release , 1992, Synapse.

[131]  Sohee Park,et al.  Schizophrenics show spatial working memory deficits. , 1992, Archives of general psychiatry.

[132]  P. Seeman.  Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[133]  N C Andreasen,et al.  Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. , 1992, Archives of general psychiatry.

[134]  D. Goff,et al.  Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. , 1992, The American journal of psychiatry.

[135]  J. Salamone,et al.  Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbens , 1992, Brain Research.

[136]  Christian Grillon,et al.  Gating and habituation of the startle reflex in schizophrenic patients. , 1992 .

[137]  A. Grace.  Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia , 1991, Neuroscience.

[138]  J. Olney,et al.  NMDA antagonist neurotoxicity: mechanism and prevention. , 1991, Science.

[139]  K. Davis,et al.  Dopamine in schizophrenia: a review and reconceptualization. , 1991, The American journal of psychiatry.

[140]  F. Benes,et al.  Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. , 1991, Archives of general psychiatry.

[141]  M. Wolf,et al.  Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine , 1991, Brain Research.

[142]  D. Javitt,et al.  Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.

[143]  J. Warter,et al.  Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat , 1991, Neuroscience Letters.

[144]  D. Mcleod,et al.  The effects of NMDA receptor blockade on the acquisition of a conditioned emotional response , 1991, Biological Psychiatry.

[145]  Douglas W. Jones,et al.  The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[146]  S. Iversen,et al.  Psychomotor activity and cognitive disruption attributable to NMDA, but not sigma, interactions in primates , 1991, Behavioural Brain Research.

[147]  P. Goldman-Rakic,et al.  D1 dopamine receptors in prefrontal cortex: involvement in working memory , 1991, Science.

[148]  M. Buchsbaum,et al.  Positron emission tomography study of phencyclidine users as a possible drug model of schizophrenia. , 1991, Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology.

[149]  R. Roth,et al.  Cognitive and motor deficits in the performance of an object retrieval task with a barrier-detour in monkeys (Cercopithecus aethiops sabaeus) treated with MPTP: long-term performance and effect of transparency of the barrier. , 1990, Behavioral neuroscience.

[150]  Ariel Y. Deutch,et al.  Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress , 1990, Brain Research.

[151]  J. Schneider,et al.  Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys , 1990, Brain Research.

[152]  R. Roth,et al.  Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys. , 1990, Brain : a journal of neurology.

[153]  C. Harley,et al.  MK-801 and AP5 impair acquisition, but not retention, of the Morris milk maze , 1990, Pharmacology Biochemistry and Behavior.

[154]  B. Bunney,et al.  Acute Effects of Typical and Atypical Antipsychotic Drugs on the Release of Dopamine from Prefrontal Cortex, Nucleus Accumbens, and Striatum of the Rat: An In Vivo Microdialysis Study , 1990, Journal of neurochemistry.

[155]  K. Jones,et al.  Differential effects of σ and phencyclidine receptor ligands on learning , 1990 .

[156]  Werner J. Schmidt,et al.  6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze , 1990, Behavioural Brain Research.

[157]  E. Kotlyarov,et al.  Single photon emission computed tomography in phencyclidine and related drug abuse. , 1990, The American journal of psychiatry.

[158]  S. Iversen,et al.  The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. , 1989, European journal of pharmacology.

[159]  R. Tandon,et al.  Cholinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic/dopaminergic interactions in schizophrenia. , 1989, Archives of general psychiatry.

[160]  G. Tremblay.  The Prefrontal Cortex , 1989, Neurology.

[161]  J. Olney,et al.  Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. , 1989, Science.

[162]  T. Svensson,et al.  Clonidine modulates dopamine cell firing in rat ventral tegmental area. , 1989, European journal of pharmacology.

[163]  L. Squire,et al.  Successful performance by monkeys with lesions of the hippocampal formation on AB and object retrieval, two tasks that mark developmental changes in human infants. , 1989, Behavioral neuroscience.

[164]  R. Post,et al.  Cocaine‐Induced Behavioral Sensitization and Kindling: Implications for the Emergence of Psychopathology and Seizures , 1988, Annals of the New York Academy of Sciences.

[165]  A Carlsson,et al.  The current status of the dopamine hypothesis of schizophrenia. , 1988, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[166]  G Honigfeld,et al.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. , 1988, Archives of general psychiatry.

[167]  S. Snyder,et al.  Psychotogenic drugs as models for schizophrenia. , 1988, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[168]  D. Weinberger,et al.  Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. , 1988, Archives of general psychiatry.

[169]  A. H. Tang,et al.  Both competitive and non-competitive antagonists of N-methyl-D-aspartic acid disrupt brightness discrimination in rats. , 1988, European journal of pharmacology.

[170]  D. Charney,et al.  Noradrenergic function in schizophrenia. , 1987, Archives of general psychiatry.

[171]  R. Roth,et al.  Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response. , 1987, European journal of pharmacology.

[172]  M Freedman,et al.  Bilateral frontal lobe disease and selective delayed response deficits in humans. , 1986, Behavioral neuroscience.

[173]  T. Robinson,et al.  Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis , 1986, Brain Research Reviews.

[174]  N. Foster,et al.  Dopamine agonist treatment of schizophrenia with N-propylnorapomorphine. , 1986, Archives of general psychiatry.

[175]  D. Weinberger,et al.  Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. , 1986, Archives of general psychiatry.

[176]  P. Goldman-Rakic,et al.  Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. , 1985, Science.

[177]  B. Bunney,et al.  The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity. , 1984, European journal of pharmacology.

[178]  M. Giannini,et al.  Comparison of Haloperidol and Chlorpromazine in the Treatment of Phencyclidine Psychosis , 1984, Journal of clinical pharmacology.

[179]  D. Segal,et al.  Increased startle responding in rats treated with phencyclidine. , 1984, Neurobehavioral toxicology and teratology.

[180]  S. Franklin,et al.  Acquisition of brightness discrimination in the rat is impaired by opiates with psychotomimetic properties , 1983, Pharmacology Biochemistry and Behavior.

[181]  B. Milner,et al.  Deficits on subject-ordered tasks after frontal- and temporal-lobe lesions in man , 1982, Neuropsychologia.

[182]  B. Milner.  Some cognitive effects of frontal-lobe lesions in man. , 1982, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[183]  A. Giannini,et al.  Physostigmine and haloperidol treatment of acute phencyclidine intoxication. , 1982, The American journal of psychiatry.

[184]  T. Perry.  Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction , 1982, Neuroscience Letters.

[185]  T. F. Murray,et al.  The effect of phencyclidine on the turnover rate of acetylcholine in various regions of rat brain. , 1981, The Journal of pharmacology and experimental therapeutics.

[186]  H. H. Kornhuber,et al.  Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia , 1980, Neuroscience Letters.

[187]  J. M. Moerschbaecher,et al.  Effects of phencyclidine, pentobarbital, and d-amphetamine on the acquisition and performance of conditional discriminations in monkeys , 1980, Pharmacology Biochemistry and Behavior.

[188]  R. Smith,et al.  Effects of acute and chronic phencyclidine on neurotransmitter enzymes in rat brain. , 1980, Biochemical pharmacology.

[189]  H. Meltzer,et al.  The effect of phencyclidine on dopamine synthesis and metabolic in rat striatum. , 1980, European journal of pharmacology.

[190]  C. Carter,et al.  Effect of 6‐Hydroxydopamine Lesions of the Medial Prefrontal Cortex on Neurotransmitter Systems in Subcortical Sites in the Rat , 1980, Journal of neurochemistry.

[191]  H. E. Rosvold,et al.  Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. , 1979, Science.

[192]  S. J. Young,et al.  Phencyclidine-induced psychosis. , 1978, The American journal of psychiatry.

[193]  C. Tamminga,et al.  Schizophrenic symptoms improve with apomorphine. , 1978, Science.

[194]  H. Kuypers,et al.  Premotor cortical ablations in monkeys: contralateral changes in visually guided reaching behavior. , 1977, Science.

[195]  P. S. Goldman,et al.  Catecholamines in neocortex of rhesus monkeys: regional distribution and ontogenetic development , 1977, Brain Research.

[196]  J. Rainey,et al.  Prolonged psychosis attributed to phencyclidine: report of three cases. , 1975, The American journal of psychiatry.

[197]  D. Ingvar,et al.  Distribution of cerebral activity in chronic schizophrenia. , 1974, Lancet.

[198]  J. Rainey,et al.  Ketamine or phencyclidine , 1974 .

[199]  Rainey Jm,et al.  Letter: Ketamine or phencyclidine. , 1974 .

[200]  I. Mirsky,et al.  Effects of psychoactive drugs on nonverbal communication and group social behavior of monkeys. , 1973, Journal of personality and social psychology.

[201]  H. E. Rosvold,et al.  Analysis of the delayed-alternation deficit produced by dorsolateral prefrontal lesions in the rhesus monkey. , 1971, Journal of comparative and physiological psychology.

[202]  H. E. Rosvold,et al.  Localization of function within the dorsolateral prefrontal cortex of the rhesus monkey. , 1970, Experimental neurology.

[203]  B. Angrist,et al.  The phenomenology of experimentally induced amphetamine psychosis--preliminary observations. , 1970, Biological psychiatry.

[204]  T. Itil,et al.  Effect of Phencyclidine in Chronic Schizophrenics * , 1967, Canadian Psychiatric Association journal.

[205]  B. Milner.  Effects of Different Brain Lesions on Card Sorting: The Role of the Frontal Lobes , 1963 .

[206]  G. Rosenbaum,et al.  Comparison of phencyclidine hydrochloride (Sernyl) with other drugs. Simulation of schizophrenic performance with phencyclidine hydrochloride (Sernyl), lysergic acid diethylamide (LSD-25), and amobarbital (Amytal) sodium; II. Symbolic and sequential thinking. , 1962, Archives of general psychiatry.

[207]  H. Beech,et al.  The effect of 1-arylcylohexylamine (sernyl) on twelve normal volunteers. , 1960, The Journal of mental science.

[208]  G. Rosenbaum,et al.  Study of a new schizophrenomimetic drug; sernyl. , 1959, A.M.A. archives of neurology and psychiatry.

[209]  E. Fey.  The performance of young schizophrenics and young normals on the Wisconsin Card Sorting Test. , 1951, Journal of Consulting Psychology.

[210]  R. Roth,et al.  Dysregulation of mesoprefrontal dopamine neurons induced by acute and repeated phencyclidine administration in the nonhuman primate: implications for schizophrenia. , 1998, Advances in pharmacology.

[211]  C. Tamminga,et al.  Schizophrenia and glutamatergic transmission. , 1998, Critical reviews in neurobiology.

[212]  D. Goldstein,et al.  Norepinephrine and schizophrenia: a new hypothesis for antipsychotic drug action. , 1998, Advances in pharmacology.

[213]  A. Grace,et al.  Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters. , 1998, Schizophrenia bulletin.

[214]  A. Grace,et al.  The modulation of corticoaccumbens transmission by limbic afferents and dopamine: a model for the pathophysiology of schizophrenia. , 1998, Advances in pharmacology.

[215]  A. Grace,et al.  Regulation of information flow in the nucleus accumbens: A model for the pathophysiology of schizophrenia. , 1998 .

[216]  A. Malhotra,et al.  Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. , 1997, The American journal of psychiatry.

[217]  D. Ziedonis,et al.  Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues. , 1997, Schizophrenia bulletin.

[218]  M. Casanova,et al.  Functional and anatomical aspects of prefrontal pathology in schizophrenia. , 1997, Schizophrenia bulletin.

[219]  P. Goldman-Rakic,et al.  Dopamine Receptors and Cognitive Function in Nonhuman Primates , 1997 .

[220]  R. Liberman,et al.  Neurocognitive deficits in schizophrenia. , 1997, The American journal of psychiatry.

[221]  J. Olney,et al.  alpha 2 adrenergic agonists prevent MK-801 neurotoxicity. , 1995, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[222]  M. Toru,et al.  Excitatory amino acids: implications for psychiatric disorders research. , 1994, Life sciences.

[223]  N. Tashiro,et al.  Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study. , 1994, Brain research.

[224]  P. Seeman,et al.  Dopamine receptor pharmacology. , 1994, Trends in pharmacological sciences.

[225]  A. Deutch.  The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. , 1992, Journal of neural transmission. Supplementum.

[226]  R. Holson,et al.  The ontogeny of behavioral sensitization to phencyclidine. , 1992, Neurotoxicology and teratology.

[227]  T. Newell,et al.  Recovery of neuropsychological functions during reduction in use of phencyclidine. , 1991, Journal of clinical psychology.

[228]  T. Goldberg,et al.  Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia. , 1991, The American journal of psychiatry.

[229]  R. Roth,et al.  The determinants of stress-induced activation of the prefrontal cortical dopamine system. , 1990, Progress in brain research.

[230]  V. Denoble,et al.  Differential effects of sigma and phencyclidine receptor ligands on learning. , 1990, European journal of pharmacology.

[231]  T. Robbins,et al.  The case of frontostriatal dysfunction in schizophrenia. , 1990, Schizophrenia bulletin.

[232]  C. Mazure,et al.  Psychotogenic drug use and neuroleptic response. , 1990, Schizophrenia bulletin.

[233]  G. Holmes.  The prefrontal cortex: Anatomy, physiology, and neuropsychology of the frontal lobe (2nd ed.) , 1989 .

[234]  D. Weinberger,et al.  The effect of apomorphine on regional cerebral blood flow in schizophrenia. , 1989, The Journal of neuropsychiatry and clinical neurosciences.

[235]  M. Geyer,et al.  Startle habituation and sensorimotor gating in schizophrenia and related animal models. , 1987, Schizophrenia bulletin.

[236]  J. Davis,et al.  A comparison of three psychotomimetic-induced models of psychosis in nonhuman primate social colonies. , 1983, Progress in clinical and biological research.

[237]  G. Pearlson.  Psychiatric and medical syndromes associated with phencyclidine (PCP) abuse. , 1981, The Johns Hopkins medical journal.

[238]  S. Snyder,et al.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. , 1976, Science.